• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证蛋白 C 在小鼠模型中的功能。

Validation for the function of protein C in mouse models.

机构信息

Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, Guangdong, China.

Department of Hematology, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, Guangdong, China.

出版信息

PeerJ. 2024 Apr 24;12:e17261. doi: 10.7717/peerj.17261. eCollection 2024.

DOI:10.7717/peerj.17261
PMID:38680896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11055512/
Abstract

OBJECTIVES

Protein C (PC) is an anticoagulant that is encoded by the PROC gene. Validation for the function of PC was carried out in mouse models.

METHODS

In this study, autosomal recessive PC deficiency (PCD) was selected as the target, and the specific mutation site was chromosome 2 2q13-q14, PROC c.1198G>A (p.Gly400Ser) which targets G399S (GGT to AGC) in mouse models. To investigate the role of hereditary PC in mice models, we used CRISPR/Cas9 gene editing technology to create a mouse model with a genetic PCD mutation.

RESULTS

The two F0 generation positive mice produced using the CRISPR/Cas9 gene editing technique were chimeras, and the mice in F1 and F2 generations were heterozygous. There was no phenotype of spontaneous bleeding or thrombosis in the heterozygous mice, but some of them were blind. Blood routine results showed no significant difference between the heterozygous mice and wild-type mice ( > 0.05). Prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT) were prolonged in the heterozygous mice, while the level of fibrinogen content (FIB) decreased, suggesting secondary consumptive coagulation disease. The protein C activity of heterozygous mice was significantly lower than that of wild-type mice ( < 0.001), but there was no significant difference in protein C antigen levels ( > 0.05). H&E staining showed steatosis and hydrodegeneration in the liver of heterozygous mice. Necrosis and exfoliated epithelial cells could be observed in renal tubule lumen, forming cell or granular tubules. Hemosiderin deposition was found in the spleen along with splenic hemorrhage. Immunohistochemistry demonstrated significant fibrin deposition in the liver, spleen, and kidney of heterozygous mice.

CONCLUSION

In this study, heterozygotes of the mouse model with a PC mutation were obtained. The function of PC was then validated in a mouse model through genotype, phenotype, and PC function analysis.

摘要

目的

蛋白 C(PC)是一种抗凝剂,由 PROC 基因编码。PC 的功能验证是在小鼠模型中进行的。

方法

本研究选择常染色体隐性 PC 缺乏症(PCD)为研究对象,其特定突变位点位于染色体 2 2q13-q14,PROC c.1198G>A(p.Gly400Ser),在小鼠模型中靶向 G399S(GGT 突变为 AGC)。为了研究遗传性 PC 在小鼠模型中的作用,我们使用 CRISPR/Cas9 基因编辑技术构建了一个具有遗传 PCD 突变的小鼠模型。

结果

使用 CRISPR/Cas9 基因编辑技术产生的 2 只 F0 代阳性小鼠均为嵌合体,F1 和 F2 代的小鼠均为杂合子。杂合子小鼠无自发性出血或血栓形成的表型,但部分小鼠失明。血常规结果显示杂合子小鼠与野生型小鼠无显著差异(>0.05)。PT、APTT 和 TT 延长,FIB 水平降低,提示继发性消耗性凝血病。杂合子小鼠的 PC 活性显著低于野生型小鼠(<0.001),但 PC 抗原水平无显著差异(>0.05)。H&E 染色显示杂合子小鼠肝脏有脂肪变性和水样变性。肾小管腔中可见坏死和脱落的上皮细胞,形成细胞或颗粒管型。脾内可见含铁血黄素沉积,伴有脾出血。免疫组化显示杂合子小鼠肝、脾、肾均有明显的纤维蛋白沉积。

结论

本研究获得了 PC 基因突变的小鼠杂合子。通过基因型、表型和 PC 功能分析,在小鼠模型中验证了 PC 的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/f6abd6fe4db5/peerj-12-17261-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/8547037c0340/peerj-12-17261-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/4094da1ef7a2/peerj-12-17261-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/2be6af58388f/peerj-12-17261-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/e6b621ddeedf/peerj-12-17261-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/406cd9ce3a3b/peerj-12-17261-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/ecd67eade7a0/peerj-12-17261-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/37db5d27475d/peerj-12-17261-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/b3374c91a16c/peerj-12-17261-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/9a8360a40337/peerj-12-17261-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/f6abd6fe4db5/peerj-12-17261-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/8547037c0340/peerj-12-17261-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/4094da1ef7a2/peerj-12-17261-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/2be6af58388f/peerj-12-17261-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/e6b621ddeedf/peerj-12-17261-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/406cd9ce3a3b/peerj-12-17261-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/ecd67eade7a0/peerj-12-17261-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/37db5d27475d/peerj-12-17261-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/b3374c91a16c/peerj-12-17261-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/9a8360a40337/peerj-12-17261-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b72/11055512/f6abd6fe4db5/peerj-12-17261-g010.jpg

相似文献

1
Validation for the function of protein C in mouse models.验证蛋白 C 在小鼠模型中的功能。
PeerJ. 2024 Apr 24;12:e17261. doi: 10.7717/peerj.17261. eCollection 2024.
2
The significance of F139V mutation on thrombotic events in compound heterozygous and homozygous protein C deficiency.F139V突变对复合杂合子和纯合子蛋白C缺乏症血栓形成事件的意义。
Blood Coagul Fibrinolysis. 2014 Dec;25(8):824-30. doi: 10.1097/MBC.0000000000000153.
3
Compound heterozygous protein C deficiency in a family with venous thrombosis: Identification and in vitro study of p.Asp297His and p.Val420Leu mutations.一个患有静脉血栓形成家族中的复合杂合蛋白C缺乏症:p.Asp297His和p.Val420Leu突变的鉴定及体外研究
Gene. 2015 May 25;563(1):35-40. doi: 10.1016/j.gene.2015.03.002. Epub 2015 Mar 4.
4
Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency.丝氨酸 252 到天冬酰胺的突变引入了一个新的 N-糖基化位点,并导致 IIb 型蛋白 C 缺乏。
Thromb Haemost. 2024 May;124(5):459-470. doi: 10.1055/s-0043-1777133. Epub 2023 Nov 27.
5
PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population.PROC c.574_576del 多态性:中国人群静脉血栓形成的常见遗传风险因素。
J Thromb Haemost. 2012 Oct;10(10):2019-26. doi: 10.1111/j.1538-7836.2012.04862.x.
6
[Gene diagnosis of four patients with protein C deficiency].[4例蛋白C缺乏症患者的基因诊断]
Zhonghua Xue Ye Xue Za Zhi. 2016 Nov 14;37(11):966-970. doi: 10.3760/cma.j.issn.0253-2727.2016.11.008.
7
Two novel compound heterozygous mutations associated with types I and II protein C deficiency with unusual phenotypes.两个与I型和II型蛋白C缺乏症相关的新型复合杂合突变,具有不寻常的表型。
Thromb Res. 2016 Sep;145:93-9. doi: 10.1016/j.thromres.2016.08.005. Epub 2016 Aug 3.
8
The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.蛋白C的ω环取代Asn2Ile与蛋白C抗凝活性降低有关。
Br J Haematol. 2009 Mar;144(6):946-53. doi: 10.1111/j.1365-2141.2008.07550.x. Epub 2008 Dec 26.
9
Different impact of two mutations of a novel compound heterozygous protein C deficiency with late onset thrombosis.一种新型复合杂合蛋白C缺乏症的两种突变对迟发性血栓形成的不同影响。
Genet Mol Res. 2014 Apr 16;13(2):2969-77. doi: 10.4238/2014.April.16.5.
10
[Phenotypic and genotypic analysis of a pedigree affected with hereditary protein C deficiency due to heterozygous deletional mutation of PROC gene].[因PROC基因杂合缺失突变导致遗传性蛋白C缺乏的家系的表型和基因型分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Oct 10;37(10):1108-1112. doi: 10.3760/cma.j.cn511374-20190625-00312.

引用本文的文献

1
Anti-Thrombotic Effects of Fibrinolytic Enzyme in Zebrafish.纤维蛋白溶解酶在斑马鱼中的抗血栓形成作用。
Nutrients. 2025 Jul 18;17(14):2358. doi: 10.3390/nu17142358.

本文引用的文献

1
Idiopathic pulmonary hemosiderosis and stroke secondary to protein C deficiency in a child with Down syndrome: a case report.特发性肺含铁血黄素沉着症和蛋白 C 缺乏继发于唐氏综合征患儿脑卒中:1 例报告
J Med Case Rep. 2023 Mar 11;17(1):105. doi: 10.1186/s13256-023-03807-2.
2
Kidney Transplantation for a Patient With Protein C Deficiency Using Activated Protein C Concentrate: A Case Report.蛋白 C 缺乏症患者应用活化蛋白 C 浓缩剂行肾移植:病例报告。
Transplant Proc. 2022 Dec;54(10):2754-2757. doi: 10.1016/j.transproceed.2022.07.019. Epub 2022 Nov 22.
3
Clinical and genetic features of Chinese pediatric patients with severe congenital protein C deficiency who first presented with purpura fulminans: A case series study and literature review.
中国首诊为暴发性紫癜的儿童严重先天性蛋白 C 缺乏症患者的临床和遗传特征:病例系列研究和文献复习。
Thromb Res. 2022 Feb;210:70-77. doi: 10.1016/j.thromres.2021.12.026. Epub 2022 Jan 3.
4
In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model.体内造血干细胞基因治疗使用双模块 HDAd5/35++ 载体治愈镰状细胞病小鼠模型。
Mol Ther. 2021 Feb 3;29(2):822-837. doi: 10.1016/j.ymthe.2020.09.001. Epub 2020 Sep 5.
5
The promise and challenge of therapeutic genome editing.治疗性基因组编辑的前景与挑战。
Nature. 2020 Feb;578(7794):229-236. doi: 10.1038/s41586-020-1978-5. Epub 2020 Feb 12.
6
Xenotransplantation: Current Status in Preclinical Research.异种移植:临床前研究的现状。
Front Immunol. 2020 Jan 23;10:3060. doi: 10.3389/fimmu.2019.03060. eCollection 2019.
7
Efficient CRISPR/Cas9-Mediated Gene Knockin in Mouse Hematopoietic Stem and Progenitor Cells.高效的 CRISPR/Cas9 介导的基因敲入在小鼠造血干细胞和祖细胞中。
Cell Rep. 2019 Sep 24;28(13):3510-3522.e5. doi: 10.1016/j.celrep.2019.08.065.
8
Ile73Asn mutation in protein C introduces a new N-linked glycosylation site on the first EGF-domain of protein C and causes thrombosis.蛋白 C 的 Ile73Asn 突变在蛋白 C 的第一个 EGF 结构域上引入了一个新的 N-糖基化位点,并导致血栓形成。
Haematologica. 2020 Jun;105(6):1712-1722. doi: 10.3324/haematol.2019.227033. Epub 2019 Aug 8.
9
Molecular mechanisms of CRISPR-Cas spacer acquisition.CRISPR-Cas 间隔区获取的分子机制。
Nat Rev Microbiol. 2019 Jan;17(1):7-12. doi: 10.1038/s41579-018-0071-7.
10
Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.经体外和体内造血干细胞基因组编辑后,β-YAC 小鼠成年后 γ-珠蛋白的重新激活。
Blood. 2018 Jun 28;131(26):2915-2928. doi: 10.1182/blood-2018-03-838540. Epub 2018 May 22.